Sign In
Buy OTIC
$0.0085
+0 (+0%)
At Close: Jul 11, 2023
A 10.6% Contrarian Play On Gunlach's Private Credit Hysteria
11:30am, Thursday, 14'th May 2026
Jeffrey Gundlach just made a scene at a very public investing conference. He blasted semi-liquid private credit funds, the $1.5 trillion corner of Wall Street that financial advisors have been quietly
OTIC Investors Have Opportunity to Join Blue Owl Technology Income Corp. Fraud Investigation with the Schall Law Firm
10:00am, Wednesday, 13'th May 2026
LOS ANGELES, May 13, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Blue Owl Technolog
OTIC Investors Have Opportunity to Join Blue Owl Technology Income Corp. Fraud Investigation with the Schall Law Firm
09:22pm, Tuesday, 28'th Apr 2026
LOS ANGELES, April 28, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Blue Owl Technol
Why Is Otonomy (OTIC) Stock Up 97% Today?
12:27pm, Tuesday, 29'th Nov 2022
Otonomy (NASDAQ: OTIC ) stock is on the move Tuesday despite a lack of news from the biopharmaceutical company. Instead, it looks like traders have latched onto OTIC stock as the next big short squeez
Best Penny Stocks To Buy? 7 To Watch Under $1 Right Now
12:22pm, Tuesday, 15'th Nov 2022
Penny stocks to buy for under $1 but are they worth the risk? The post Best Penny Stocks To Buy?
These Were the Five Best and Worst Performing Healthcare Stocks in Q3 2022
09:21pm, Monday, 24'th Oct 2022
The healthcare industry is now starting to shift its focus away from the coronavirus pandemic to work on its core activities.
Otonomy, Inc. (OTIC) CEO Dave Weber on Q2 2022 Results - Earnings Call Transcript
08:18pm, Monday, 25'th Jul 2022
Otonomy, Inc. (NASDAQ:OTIC ) Q2 2022 Earnings Conference Call July 25, 2022 4:30 PM ET Company Participants Robert Uhl - Managing Director, ICR Westwicke Dave Weber - Chief Executive Officer, Presiden
Otonomy to Report Second Quarter 2022 Financial Results and Provide Corporate Update
07:30am, Monday, 18'th Jul 2022
SAN DIEGO, July 18, 2022 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced it wil
Otonomy, Inc. (OTIC) CEO Dr. David Weber on Q1 2022 Results - Earnings Call Transcript
10:21pm, Monday, 09'th May 2022
Otonomy, Inc. (NASDAQ:OTIC ) Q1 2022 Earnings Conference Call May 9, 2022 4:30 PM ET Company Participants Robert Uhl - IR David Weber - President, CEO and Director Paul Cayer - Chief Financial & Busin
Otonomy to Report First Quarter 2022 Financial Results and Provide Corporate Update
07:30am, Monday, 02'nd May 2022
SAN DIEGO, May 02, 2022 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced it will
Otonomy: Hearing Loss And Tinnitus Data In 2022
12:23pm, Monday, 04'th Apr 2022
Data for OTO-413 in hearing loss is due early in Q2 2002.
Otonomy, Inc. 2021 Q4 - Results - Earnings Call Presentation
06:20am, Tuesday, 01'st Mar 2022 Seeking Alpha
Otonomy (OTIC) Q4 2021 Earnings Call Transcript
02:00am, Tuesday, 01'st Mar 2022 The Motley Fool
OTIC earnings call for the period ending December 31, 2021.
Otonomy, Inc. (OTIC) CEO Dr. David Weber on Q4 2021 Results - Earnings Call Transcript
12:41am, Tuesday, 01'st Mar 2022 Seeking Alpha
Otonomy GAAP EPS of -$0.20 misses by $0.02
09:33pm, Monday, 28'th Feb 2022 Seeking Alpha
Otonomy press release (NASDAQ:OTIC): Q4 GAAP EPS of -$0.20 misses by $0.02.
